While the association of CRP and circulating RAGEs with cardiovascular events and mortality in T2D has been extensively explored [7, 68], our data might suggest the incorporation of CXCL10, CXCL11, and estimates of specific immune cell subpopulations into a prognostic signature. The gene discussed is CXCL11; the disease is type 2 diabetes mellitus.